Enabling a Renin-Angiotensin System Inhibitor and/or a Mineralocorticoid Receptor Antagonist in Patients With Heart Failure and/or Chronic Kidney Disease

Key Points

• This research aims to assess the impact of renin-angiotensin system inhibitors and mineralocorticoid receptor antagonists on patients with heart failure and chronic kidney disease.
• Randomized trial
• Evaluated the impact of specific pharmacological interventions
• Population included heart failure and chronic kidney disease patients.
• Improved clinical outcomes were observed with the use of either inhibitor treatment.
• Patients showed significant reductions in heart failure symptoms and enhanced kidney function.